Francesco Rosetti

2.4k total citations
23 papers, 1.1k citations indexed

About

Francesco Rosetti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Francesco Rosetti has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Francesco Rosetti's work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (9 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Francesco Rosetti is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (9 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Francesco Rosetti collaborates with scholars based in Italy, Switzerland and Canada. Francesco Rosetti's co-authors include Ciro Gallo, Cesare Gridelli, Santi Barbera, Francesco Perrone, Luigi Manzione, Sergio Robbiati, S. Cigolari, Elena Piazza, Luciano Frontini and Alessandra Bearz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Francesco Rosetti

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesco Rosetti Italy	13	640	437	149	139	136	23	1.1k
Santi Barbera Italy	10	632 1.0×	456 1.0×	148 1.0×	113 0.8×	72 0.5×	17	978
Carlos Jara Spain	20	795 1.2×	179 0.4×	85 0.6×	131 0.9×	234 1.7×	58	1.4k
Arati V. Rao United States	19	446 0.7×	173 0.4×	226 1.5×	49 0.4×	196 1.4×	57	1.2k
Tracey L. O’Connor United States	17	944 1.5×	332 0.8×	64 0.4×	94 0.7×	195 1.4×	59	1.4k
Katia Cannita Italy	18	596 0.9×	217 0.5×	64 0.4×	96 0.7×	130 1.0×	79	918
I. Krakowski France	18	676 1.1×	619 1.4×	28 0.2×	151 1.1×	137 1.0×	108	1.5k
Jean Pierre Droz France	15	235 0.4×	217 0.5×	91 0.6×	574 4.1×	127 0.9×	24	1.0k
Trevor A. Jolly United States	14	460 0.7×	252 0.6×	378 2.5×	69 0.5×	88 0.6×	32	953
Melissa Accordino United States	18	445 0.7×	222 0.5×	41 0.3×	88 0.6×	101 0.7×	98	905
Juan Antonio Virizuela Spain	12	231 0.4×	165 0.4×	56 0.4×	127 0.9×	78 0.6×	57	587

Countries citing papers authored by Francesco Rosetti

Since Specialization

Citations

This map shows the geographic impact of Francesco Rosetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Rosetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Rosetti more than expected).

Fields of papers citing papers by Francesco Rosetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Rosetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Rosetti. The network helps show where Francesco Rosetti may publish in the future.

Co-authorship network of co-authors of Francesco Rosetti

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Rosetti. A scholar is included among the top collaborators of Francesco Rosetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Rosetti. Francesco Rosetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Piccirillo, Maria Carmela, Laura Bonanno, Marina Chiara Garassino, et al.. (2021). 1207O Bevacizumab + erlotinib vs erlotinib alone as first-line treatment of pts with EGFR mutated advanced non squamous NSCLC: Final analysis of the multicenter, randomized, phase III BEVERLY trial. Annals of Oncology. 32. S950–S950. 8 indexed citations

Camerini, Andrea, Giuseppe Luigi Banna, Saverio Cinieri, et al.. (2018). Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis. Clinical & Translational Oncology. 21(6). 790–795. 22 indexed citations

Nanni, Oriana, D. Amadori, Andrea De Censi, et al.. (2018). Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial. Breast Cancer Research and Treatment. 174(2). 433–442. 73 indexed citations

Piccirillo, Maria Carmela, Alessandro Morabito, Paolo Maione, et al.. (2017). Effect on quality of life (QOL) of adding cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicentre, randomized, phase 3 MILES-3 and MILES-4 studies. Annals of Oncology. 28. v488–v488. 1 indexed citations

Dazzi, Claudio, Alessandro Gamboni, Angelo Delmonte, et al.. (2017). Randomized cross-over study of patient preference for oral or intravenous vinorelbine in the treatment of advanced NSCLC: A phase IV study.. Journal of Clinical Oncology. 35(15_suppl). e20676–e20676.

Gridelli, Cesare, Alessandro Morabito, Luigi Cavanna, et al.. (2017). Efficacy of the addition of cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicenter, randomized phase III MILES-3 and MILES-4 studies.. Journal of Clinical Oncology. 35(15_suppl). 9002–9002. 5 indexed citations

Capelletto, Enrica, Simona Carnio, Cesare Gridelli, et al.. (2016). Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non–Small-cell Lung Cancer: A Multicenter Italian Survey. Clinical Lung Cancer. 18(4). 381–387. 6 indexed citations

Bearz, Alessandra, Renato Talamini, Gilda Rossoni, et al.. (2012). Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience. BMC Research Notes. 5(1). 482–482. 33 indexed citations

Grossi, Francesco, Marianna Aita, Carlotta Defferrari, et al.. (2009). Impact of Third-Generation Drugs on the Activity of First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analytical Approach. The Oncologist. 14(5). 497–510. 49 indexed citations

10.

Sartori, Donata, et al.. (2009). Brain metastases in breast cancer: Different survival by biological subtype and Ki67 expression. Journal of Clinical Oncology. 27(15_suppl). 1069–1069. 1 indexed citations

11.

Grossi, Francesco, Carlotta Defferrari, Orazio Vinante, et al.. (2007). B2-07: Impact of 3rd generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): a meta-analytical approach. Journal of Thoracic Oncology. 2(8). S339–S339. 2 indexed citations

12.

Gridelli, Cesare, Ciro Gallo, Anna Ceribelli, et al.. (2007). Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. The Lancet Oncology. 8(6). 500–512. 79 indexed citations

13.

Maïo, Massimo Di, Cesare Gridelli, Ciro Gallo, et al.. (2005). Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials. The Lancet Oncology. 6(9). 669–677. 181 indexed citations

14.

Maione, Paolo, Francesco Perrone, Ciro Gallo, et al.. (2005). Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study. Journal of Clinical Oncology. 23(28). 6865–6872. 352 indexed citations

15.

Azzarello, Giuseppe, Giovanni Pappagallo, Donata Sartori, et al.. (2005). Salvage Therapy with Capecitabine Plus Weekly Paclitaxel in Heavily Pretreated Advanced Breast Cancer. 4(5). 307–313. 5 indexed citations

16.

Maïo, Massimo Di, Federica Perrone, Ciro Gallo, et al.. (2003). Supportive care in patients with advanced non-small-cell lung cancer. British Journal of Cancer. 89(6). 1013–1021. 19 indexed citations

17.

Azzarello, Giuseppe, Maria Teresa Valenti, Giovanni Pappagallo, et al.. (2003). The Impact of Progenitor Enrichment, Serum, and Cytokines on the Ex Vivo Expansion of Mobilized Peripheral Blood Stem Cells: A Controlled Trial. Stem Cells. 21(1). 33–40. 19 indexed citations

18.

Azzarello, Giuseppe, et al.. (2000). Hypnosis in the Treatment of Anticipatory Nausea and Vomiting in Patients Receiving Cancer Chemotherapy. Oncology. 59(2). 100–104. 55 indexed citations

19.

Marchioro, G., Giuseppe Azzarello, Francesco Rosetti, et al.. (1996). The impact of a psychological intervention on quality of life in non-metastatic breast cancer. European Journal of Cancer. 32(9). 1612–1615. 75 indexed citations

20.

Vinante, Orazio, et al.. (1993). The Combination of Mitomycin, Vinblastine and Cisplatin Is Active in the Palliation of Stage IIIB- IV Non-Small-Cell Lung Cancer. Oncology. 50(1). 1–4. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact